DAT

Direct Coombs Test

Hemograma

Última revisão: 7 de abril de 2026. Abordagem de fontes: contexto padrão de interpretação laboratorial, material médico de referência e orientações clínicas ou de saúde pública quando relevantes.

O que é Direct Coombs Test?

The direct Coombs test, also known as the direct antiglobulin test (DAT), detects antibodies or complement proteins that are bound directly to the surface of red blood cells (RBCs) in vivo. The test is performed by washing the patient's red blood cells to remove unbound proteins, then adding anti-human globulin (AHG, also called Coombs reagent). If IgG antibodies or complement component C3d are attached to the RBC surface, the AHG will cross-link them, causing visible agglutination.

The DAT is a cornerstone of transfusion medicine and hematology. It is the primary test for diagnosing autoimmune hemolytic anemia (AIHA), evaluating transfusion reactions, investigating hemolytic disease of the fetus and newborn (HDFN), and detecting drug-induced immune hemolysis. The strength of the agglutination reaction is graded from 1+ to 4+, with stronger reactions generally correlating with more significant antibody coating, though clinical severity does not always parallel DAT strength.

Por que isso importa

The direct Coombs test is essential for determining whether hemolysis (red blood cell destruction) is immune-mediated. A positive DAT in the setting of anemia and evidence of hemolysis (elevated LDH, low haptoglobin, elevated indirect bilirubin, reticulocytosis) confirms autoimmune hemolytic anemia and guides treatment. It is also critical in evaluating transfusion reactions—a newly positive DAT after transfusion suggests an acute or delayed hemolytic transfusion reaction. In newborns with jaundice, a positive DAT helps confirm hemolytic disease of the newborn.

Faixas de referência normais

Grupo	Faixa	Unidade
Adults and children	Negative	(no agglutination)

As faixas de referência podem variar entre laboratórios. Sempre compare seus resultados com as faixas fornecidas pelo seu local de exame.

O que significam níveis altos de DAT

Causas comuns

Warm autoimmune hemolytic anemia (IgG-mediated)
Cold agglutinin disease (complement-mediated)
Drug-induced immune hemolytic anemia (penicillin, cephalosporins, methyldopa)
Hemolytic transfusion reactions
Hemolytic disease of the fetus and newborn (Rh or ABO incompatibility)
Systemic lupus erythematosus
Chronic lymphocytic leukemia
Evans syndrome (AIHA + immune thrombocytopenia)

Possíveis sintomas

Fatigue and weakness
Jaundice (yellowing of skin and eyes)
Dark urine (hemoglobinuria)
Pallor
Rapid heart rate
Shortness of breath
Splenomegaly (enlarged spleen)

O que fazer: A positive DAT should be interpreted alongside clinical findings: complete blood count, reticulocyte count, haptoglobin, LDH, and indirect bilirubin. Monospecific DAT (testing separately for IgG and C3d) helps classify the type of immune hemolysis and guide therapy. Warm AIHA (IgG-positive) is typically treated with corticosteroids, while cold agglutinin disease (C3d-positive) responds poorly to steroids and may require rituximab. Drug causes should be investigated and the offending agent discontinued.

O que significam níveis baixos de DAT

Causas comuns

Normal result—no antibodies or complement bound to RBCs
DAT-negative autoimmune hemolytic anemia (rare, ~5% of AIHA cases)

Possíveis sintomas

No symptoms associated with a negative DAT

O que fazer: A negative DAT is the expected normal result. If clinical suspicion for immune hemolysis is high despite a negative DAT, more sensitive techniques such as flow cytometry, gel-based DAT, or eluate studies may detect low-level antibody coating not detected by standard tube methods.

Quando o exame de DAT é recomendado?

Evaluating unexplained hemolytic anemia
Investigating a suspected transfusion reaction
Workup of neonatal jaundice or hemolytic disease of the newborn
Suspected drug-induced hemolysis
Autoimmune disease workup with cytopenias

Perguntas frequentes

The direct Coombs test (DAT) detects antibodies already bound to the patient's red blood cells in vivo, used to diagnose immune hemolysis. The indirect Coombs test (IAT) detects free antibodies in the patient's serum that could potentially bind to donor red blood cells, used primarily in pretransfusion testing and prenatal screening.

Yes. Up to 0.1% of healthy blood donors and 1–15% of hospitalized patients have a positive DAT without clinical hemolysis. This can occur with certain medications, after intravenous immunoglobulin administration, or as an incidental finding. A positive DAT is clinically significant only when accompanied by evidence of hemolysis.

Not always. While a strongly positive DAT (3–4+) often indicates significant antibody coating, the clinical severity of hemolysis depends on many factors including antibody type, thermal amplitude, complement activation, and splenic function. Some patients with weakly positive DATs may have severe hemolysis, while others with strongly positive results may be asymptomatic.

Biomarcadores relacionados

IATIndirect Coombs Test HgbHemoglobina ReticReticulocyte Count

Leitura relacionada

Condições

Anemia →

Referências e abordagem de revisão

As páginas do glossário de biomarcadores são explicações educativas e devem ser interpretadas junto com as faixas de referência e observações fornecidas pelo seu laboratório e pelo seu médico. Para conhecer nossos padrões editoriais e processo de revisão, veja nossa Política editorial e a nossa revisão de conteúdo.

Quer analisar seus níveis de DAT?

Envie seus resultados de exames para receber uma análise instantânea com IA de todos os seus biomarcadores.

Enviar resultados de exames →

Aviso médico: Estas informações são apenas educativas e não substituem orientação, diagnóstico ou tratamento médico profissional. As faixas de referência podem variar entre laboratórios. Sempre converse com seu profissional de saúde sobre a interpretação dos seus resultados específicos.